AI
Aju IB
Aju IB is a seed to Series D stage investment firm. It has made 5 investments. Their most common stage is series-c (50% of deals). Average disclosed round size is $42.5M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
TS
Timothy Sullivan
Venture Partner
SD
Seunghyeon David Kim
Executive Director | Head of Investment Strategy
WS
Woogie Suh
Investment Director
BK
Bong Kyu Song
투자팀장 (Investment Team Lead)
SO
Soohan Oh
Investment Professional
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kristin Company | Series A | — | Nov 2023 |
| SS Alpha Therapeutics | Seed | $8.7M | Jul 2021 |
| AAmphivena Therapeutics | Series C | $62M | Sep 2019 |
| AAmphivena | Series C | $62M | Sep 2019 |
| AApellis | Series D | $47M | — |
| AApellis | Series C | $33M | — |
Top Co-Investors
AJU IB Investment4 shared
Tekla Capital Management2 shared
NanoDimension2 shared
MPM Capital2 shared
Korea Development Bank1 shared
NAVER D2SF1 shared
Korea Investment Partners1 shared
Timewise Investment1 shared
STIC Investments, Inc.1 shared
Korys1 shared
Cormorant Asset Management1 shared
Hillhouse Capital1 shared
F-Prime Capital1 shared
Epidarex Capital1 shared
Morningside1 shared
Morningside Ventures1 shared
Last updated: 14 September 2026